Skip to main content
Figure 7 | Journal of Translational Medicine

Figure 7

From: Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

Figure 7

MART-1 tetramer positive cells detected in a melanoma patient upon vaccination. Patient's PBMC was analyzed for % MART-1 tetramer positive cells. Cells stained with negative control tetramer (upper panel) and MART-1 tetramer (lower panel) is shown. Tetramer positive cells in dot blots on gated viable lymphocytes are shown. No binding is seen among CD8 negative cell population. Percent tetramer positive cells shown are calculated based on gated viable CD8+ T cells. Trend analysis demonstrated statistical significant linear response.

Back to article page